Reference tables for 2.5, 5, 7.5, 10, 12.5, and 15 mg at common concentrations
Antimicrob Agents Chemother 1989;33:474-8
Although data on HR were not provided in most studies of twice-daily exenatide, HR elevation was generally more apparent in the GLP-1 RA treatment arms, compared with the comparator arms (Table 2)
Starting low, progressing gradually, and adjusting thoughtfully creates the best foundation for long-term success and a better overall experience
Key Benefits: GLP-1 medication that helps regulate appetite and support healthier eating habits
Therefore, successful long term management requires comprehensive blood testing and necessary Hormonal Resistance management alongside the GLP-1 therapy immediately